LUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031

Stock News06-11

LUYE PHARMA (SEHK: 02186) has announced the successful completion of its convertible bond issuance. The company confirmed that all conditions precedent under the subscription agreement have been satisfied. The issuance of bonds with a total principal amount of US$180 million was finalized on June 10, 2026.

These bonds have been listed on the Vienna Stock Exchange, effective from June 10, 2026. The initial conversion price has been set at HK$2.71 per share. This price represents a premium of approximately 24.9% over the closing price of HK$2.170 on the Hong Kong Stock Exchange on June 3, 2026, which was the trading day the subscription agreement was signed.

Furthermore, the initial conversion price also represents a premium of about 24.1% over the average closing price of HK$2.184 per share for the last five consecutive trading days up to and including June 2, 2026. The Hong Kong Stock Exchange has granted approval for the listing and trading of the shares to be issued upon conversion of these bonds.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163526407?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 08:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163526407","market":"nz","top_or_hot":-1,"title":"LUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031","media":"Stock News","content":"<p><b>LUYE PHARMA</b> (<b>SEHK: 02186</b>) has announced the successful completion of its convertible bond issuance. The company confirmed that all conditions precedent under the subscription agreement have been satisfied. The issuance of bonds with a total principal amount of US$180 million was finalized on June 10, 2026.<br><br>These bonds have been listed on the Vienna Stock Exchange, effective from June 10, 2026. The initial conversion price has been set at HK$2.71 per share. This price represents a premium of approximately 24.9% over the closing price of HK$2.170 on the Hong Kong Stock Exchange on June 3, 2026, which was the trading day the subscription agreement was signed.<br><br>Furthermore, the initial conversion price also represents a premium of about 24.1% over the average closing price of HK$2.184 per share for the last five consecutive trading days up to and including June 2, 2026. The Hong Kong Stock Exchange has granted approval for the listing and trading of the shares to be issued upon conversion of these bonds.<br><br></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-11 08:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>LUYE PHARMA</b> (<b>SEHK: 02186</b>) has announced the successful completion of its convertible bond issuance. The company confirmed that all conditions precedent under the subscription agreement have been satisfied. The issuance of bonds with a total principal amount of US$180 million was finalized on June 10, 2026.<br><br>These bonds have been listed on the Vienna Stock Exchange, effective from June 10, 2026. The initial conversion price has been set at HK$2.71 per share. This price represents a premium of approximately 24.9% over the closing price of HK$2.170 on the Hong Kong Stock Exchange on June 3, 2026, which was the trading day the subscription agreement was signed.<br><br>Furthermore, the initial conversion price also represents a premium of about 24.1% over the average closing price of HK$2.184 per share for the last five consecutive trading days up to and including June 2, 2026. The Hong Kong Stock Exchange has granted approval for the listing and trading of the shares to be issued upon conversion of these bonds.<br><br></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1163526407","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163526407","pubTimestamp":1781136421,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LUYE PHARMA (SEHK: 02186) has announced the successful completion of its convertible bond issuance. The company confirmed that all conditions precedent under the subscription agreement have been...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","02186":"绿叶制药","BK1606":"中医药概念","BK1191":"制药","BNDW":"Vanguard Total World Bond ETF"},"translate_title":"绿叶制药成功发行1.8亿美元2031年到期可转换票据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNDW":1,"ZFmain":1,"TNmain":1,"02186":1,"ZBmain":1,"ZTmain":1,"UBmain":1,"ZNmain":1},"content_text":"LUYE PHARMA (SEHK: 02186) has announced the successful completion of its convertible bond issuance. The company confirmed that all conditions precedent under the subscription agreement have been satisfied. The issuance of bonds with a total principal amount of US$180 million was finalized on June 10, 2026.These bonds have been listed on the Vienna Stock Exchange, effective from June 10, 2026. The initial conversion price has been set at HK$2.71 per share. This price represents a premium of approximately 24.9% over the closing price of HK$2.170 on the Hong Kong Stock Exchange on June 3, 2026, which was the trading day the subscription agreement was signed.Furthermore, the initial conversion price also represents a premium of about 24.1% over the average closing price of HK$2.184 per share for the last five consecutive trading days up to and including June 2, 2026. The Hong Kong Stock Exchange has granted approval for the listing and trading of the shares to be issued upon conversion of these bonds.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163526407","isCrawlerRequest":true}